Of the dozens under development, Drucker says two have especially high potential to move the needle. The first, called retatrutide, is being developed by the same manufacturer as tirzepatide and would be the first to interact with a third receptor in addition to GLP-1 and GIP
Semaglutide injections represent a proven weight management option, with clinical studies showing participants lose an average of 15% of body weight over 68 weeks
A folic acid iv drip or injection can help improve low folate levels
Last reviewed: June 21, 2026 Last updated: June 21, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Misra has taken Ozempic herself and also usually recommends that patients start out taking Ozempic at night